MAZ and cancer: Since high level of SAF-1 in breast cancer is linked to angiogenesis, cancer cell proliferation and metastasis, a new approach to curb the activity of SAF-1 using microRNA may provide a new option in pharmacological treatment for breast cancer therapy.